Microbot Medical Inc.
NASDAQ:MBOTMedical - Instruments & Supplies
-$0.06 today
- Market cap
- $65.73M
- Beta
- 1.04
- P/E (TTM)
- -8.6
- EPS (TTM)
- -$0.21
Volume 0.87M
Average 1.60M
MBOT Long-term Debt
Borrowings due after more than one year.
Microbot Medical Inc.NASDAQ: MBOT
Long-term Debt · Q1 FY2026 · quarter ended Mar 2026
Long-term debt remains negative
Q1 FY2026 long-term debt was $574K, compared with $0 a year earlier.
Context
- Long-term debt amounted to 0.7% of total assets at the end of Q1 FY2026, up 0.7 pp from a year earlier.
- Long-term debt increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
Sources:Balance SheetText generated from reported figures; not investment advice.
Long-term Debt history
USD · from the balance sheet
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Long-term Debt | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Long-term Debt vs competitors
How MBOT compares with its peers on the latest reported figures
- Peers report in different currencies, so long-term debt is compared through growth and share of total assets rather than absolute size.
- Long-term debt amounts to 0.7% of total assets for MBOT, versus a peer median of 0.2%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $16.49M USD | — | — | 38.9% | |
| Mar 2026 | $16.34M USD | +26.5% | -11.1% | 75.4% | |
| Mar 2026 | $1.98M USD | -95.2% | — | 3.8% | |
| Mar 2026 | CA$1.76M CAD | — | — | 11.6% | |
| Mar 2026 | $574K USD | — | — | 0.7% | |
| Mar 2026 | $171.71K USD | +7868.2% | -47.0% | 0.1% | |
| Mar 2026 | $122.37K USD | +48.1% | — | 0.2% | |
| Mar 2026 | $0 USD | — | — | 0.0% | |
| Mar 2026 | $0 USD | — | — | 0.0% | |
| Mar 2026 | CA$0 CAD | — | — | 0.0% | |
| Peer median (excluding MBOT) | — | +37.3% | -29.0% | 0.2% | |
Competitors are the stored peer set for MBOT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Microbot Medical Inc.
NASDAQ:MBOT
Intrinsic Alpha fair value
Locked
Current Price
$0.98
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.